These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35270205)

  • 21. Spatial and temporal variability of idiopathic pulmonary fibrosis cases in Silesian Voivodeship in years 2006-2010.
    Niewiadomska E; Kowalska M; Zejda JE
    Int J Occup Med Environ Health; 2017 Jun; 30(4):593-601. PubMed ID: 28584328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region.
    Mennini FS; Sciattella P; Marcellusi A; Toraldo B; Koch M
    Dig Liver Dis; 2017 Sep; 49(9):1003-1008. PubMed ID: 28663067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic pulmonary fibrosis in Taiwan - a population-based study.
    Lai CC; Wang CY; Lu HM; Chen L; Teng NC; Yan YH; Wang JY; Chang YT; Chao TT; Lin HI; Chen CR; Yu CJ; Wang JD
    Respir Med; 2012 Nov; 106(11):1566-74. PubMed ID: 22954482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global incidence and prevalence of idiopathic pulmonary fibrosis.
    Maher TM; Bendstrup E; Dron L; Langley J; Smith G; Khalid JM; Patel H; Kreuter M
    Respir Res; 2021 Jul; 22(1):197. PubMed ID: 34233665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
    Kondoh Y; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Homma S
    Respir Res; 2022 Feb; 23(1):24. PubMed ID: 35135550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbidities and risk of mortality among hospitalized patients with idiopathic pulmonary fibrosis in Spain from 2002 to 2014.
    Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Esteban-Hernández J; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
    Respir Med; 2018 May; 138():137-143. PubMed ID: 29724386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
    Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.
    Ley B; Urbania T; Husson G; Vittinghoff E; Brush DR; Eisner MD; Iribarren C; Collard HR
    Ann Am Thorac Soc; 2017 Jun; 14(6):880-887. PubMed ID: 28355518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Idiopathic Pulmonary Fibrosis among U.S. Veterans, 2010-2019.
    Kaul B; Lee JS; Zhang N; Vittinghoff E; Sarmiento K; Collard HR; Whooley MA
    Ann Am Thorac Soc; 2022 Feb; 19(2):196-203. PubMed ID: 34314645
    [No Abstract]   [Full Text] [Related]  

  • 30. The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy.
    Conti S; Harari S; Caminati A; Zanobetti A; Schwartz JD; Bertazzi PA; Cesana G; Madotto F
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29371377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
    Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
    BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience.
    Isshiki T; Sakamoto S; Yamasaki A; Shimizu H; Miyoshi S; Nakamura Y; Homma S; Kishi K
    Respir Med; 2021 Oct; 187():106551. PubMed ID: 34343721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena.
    Vietri L; Cameli P; Perruzza M; Cekorja B; Bergantini L; d'Alessandro M; Refini RM; Pieroni M; Fossi A; Bennett D; Spalletti M; Mazzei MA; Sestini P; Rottoli P; Bargagli E
    Ther Adv Respir Dis; 2020; 14():1753466620906326. PubMed ID: 32066332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study.
    Poletti V; Vancheri C; Albera C; Harari S; Pesci A; Metella RR; Campolo B; Crespi G; Rizzoli S;
    Respir Res; 2021 Feb; 22(1):66. PubMed ID: 33627105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis.
    Mooney J; Reddy SR; Chang E; Broder MS; Gokhale S; Corral M
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1724-1733. PubMed ID: 34818092
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study.
    Dalleywater W; Powell HA; Hubbard RB; Navaratnam V
    Chest; 2015 Jan; 147(1):150-156. PubMed ID: 25121965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001-2013.
    Marshall DC; Salciccioli JD; Shea BS; Akuthota P
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29348182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Rationale, Methodology, and Aims of a Greek Prospective Idiopathic Pulmonary Fibrosis Registry: Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF).
    Bouros D; Daniil Z; Papakosta D; Antoniou KM; Markopoulou K; Kolilekas L; Konstantopoulos G; Papiris S;
    Respiration; 2018 Mar; 96(1):41-47. PubMed ID: 29514162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.
    Tarride JE; Hopkins RB; Burke N; Guertin JR; O'Reilly D; Fell CD; Dion G; Kolb M
    Clinicoecon Outcomes Res; 2018; 10():127-137. PubMed ID: 29503576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
    Raghu G; Chen SY; Yeh WS; Maroni B; Li Q; Lee YC; Collard HR
    Lancet Respir Med; 2014 Jul; 2(7):566-72. PubMed ID: 24875841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.